HMGA2 overexpression in polycythemia vera with t(12;21)(q14;q22)

Cancer Genetics and Cytogenetics

Volumn 177, Issue 2, 2007, Pages 115-119

  Aliano, Stefania ^a   Cirmena, Gabriella ^a   Garuti, Anna ^a   Fugazza, Giuseppina ^a   Bruzzone, Roberto ^a   Rocco, Ilaria ^a   Malacarne, Michela ^b   Ballestrero, Alberto ^a   Sessarego, Mario ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b GALLIERA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; HYDROXYUREA;

AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CASE REPORT; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 12; CLINICAL FEATURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; MYELOPROLIFERATIVE DISORDER; PATHOGENESIS; PHILADELPHIA CHROMOSOME NEGATIVE CELL; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS;

AGED; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 21; FEMALE; HMGA2 PROTEIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; PHILADELPHIA CHROMOSOME; POLYCYTHEMIA VERA; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC;

BACTERIA (MICROORGANISMS);

EID: 34548516186     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.05.009     Document Type: Article

References (19)

1. Beitzel B., and Bushman F. Construction and analysis of cells lacking the HMGA gene family. Nucleic Acids Res 31 (2003) 5025-5032
2. Tessari M.A., Gostissa M., Altamura S., Sgarra R., Rustighi A., Salvagno C., Caretti G., Imbriano C., Mantovani R., Del Sal G., Giancotti V., and Manfioletti G. Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. Mol Cell Biol 23 (2003) 9104-9116
3. Gattas G.J., Quade B.J., Nowak R.A., and Morton C.C. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer 25 (1999) 316-322
4. Schoenmakers E.F., Wanschura S., Mols R., Bullerdiek J., Van den Berghe H., and Van de Ven W.J. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 10 (1995) 436-444
5. Abe N., Watanabe T., Suzuki Y., Matsumoto N., Masaki T., Mori T., Sugiyama M., Chiappetta G., Fusco A., and Atomi Y. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer 89 (2003) 2104-2109
6. Finelli P., Pierantoni G.M., Giardino D., Losa M., Rodeschini O., Fedele M., Valtorta E., Mortini P., Croce C.M., Larizza L., and Fusco A. The high mobility group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res 62 (2002) 2398-2405
7. Masciullo V., Baldasserre G., Pentimalli F., Berlingeri M.T., Boccia A., Chiappetta G., Palazzo J., Manfioletti G., Giancotti V., Viglietto G., Scambia G., and Fusco A. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. Carcinogenesis 24 (2003) 1191-1198
8. Crombez K.R., Vanoirbeek E.M., Van de Ven W.J., and Petit M.M. Transactivation functions of the tumor-specific HMGA2/LPP fusion protein are augmented by wild-type HMGA2. Mol Cancer Res 3 (2005) 63-70
9. Andrieux J., Demory J.L., Dupriez B., Quief S., Plantier I., Roumier C., Bauters F., Lai J.L., and Kerckaert J.P. Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer 39 (2004) 82-87
10. Odero M.D., Grand F.H., Iqbal S., Roman J.P., Vizmanos J.L., Andrieux J., Lai J.L., Calasanz M.J., and Cross N.C. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 19 (2005) 245-252
11. Storlazzi C.T., Albano F., Lo Cunsolo C., Lonoce A., Funes S., Guastadisegni M.C., Cimarosto L., Impera L., D'Addabbo P., Panagopoulos I., Specchia G., and Rocchi M. t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene. Leukemia 20 (2006) 2190-2192
12. James C., Ugo V., and Le Couedic J.P. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera. Nature 434 (2005) 1144-1148
13. Campbell P., and Green A. The myeloproliferative disorders. N Engl J Med 355 (2006) 2452-2466
14. Cerignoli F., Ambrosi C., Mellone M., Assimi I., di Marcotullio L., Gulino A., and Giannini G. HMGA molecules in neuroblastic tumors. Ann N Y Acad Sci 1028 (2004) 122-132
15. Ballestrero A., Coviello D.A., Garuti A., Nencioni A., Fama A., Rocco I., Bertorelli R., Ferrando F., Gonella R., and Patrone F. Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. Cancer 92 (2001) 2030-2035
16. Fugazza G., Garuti A., Marchelli S., Miglino M., Bruzzone R., Gatti A.M., Castello S., and Sessarego M. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myeloid leukemia. Cancer Genet Cytogenet 163 (2005) 173-175
17. Borrmann L., Wilkening S., and Bullerdiek J. The expression of HMGA genes is regulated by their 3′UTR. Oncogene 20 (2001) 4537-4541
18. Stenman G. Fusion oncogenes and tumor type specificity: insights from salivary gland tumors. Semin Cancer Biol 15 (2005) 224-235
19. Borrmann L., Schwanbeck R., Heyduk T., Seebeck B., Rogalla P., Bullerdiek J., and Wisniewski J. High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity. Nucleic Acids Res 31 (2003) 6841-6851